A cancer dilemma
Submitted by ipsita on Tue, 1997-12-09 10:30
A nod of approval from a U.S. Food and Drug Administration advisory committee means that tamoxifen, a powerful drug now given to some women to prevent a recurrence of breast cancer, may soon become
Main Topic:
Mark Content Private(Internal):
Clipping Type:
DNB
External URL:
Main Type:
dte-DNB
Publication Date:
09/12/1997